High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.
about
Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern ChinaEvaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studiesEvaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in EstoniaExpanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, EstoniaCombined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, EstoniaThe success factors of scaling-up Estonian sexual and reproductive health youth clinic network--from a grassroots initiative to a national programme 1991-2013.Estonia at the threshold of the fourth decade of the AIDS era in EuropeMultiple routes of drug administration and HIV risk among injecting drug usersCan HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.A decline in the prevalence of injecting drug users in Estonia, 2005-2009.The importance of measuring and accounting for potential biases in respondent-driven samples.Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.Informed recruitment in partner studies of HIV transmission: an ethical issue in couples researchHIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.Comparison of HIV risk by duration of injection drug use.High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.Reported contraceptive use, risk behaviours and STIs among military conscripts in Estonian defence forces.Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China.A surveillance report of HIV status and high risk behaviors among rapid testing participants in Tallinn, Estonia.Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia.Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia
P2860
Q27487103-33F0F1C9-68E0-4082-98D8-0B288DB8A67BQ33637683-CCCD06D6-1C3E-4114-9DA1-CF04A5E23C55Q33754339-0A42115D-8EB7-4C06-9A5D-EA5C94BC7F3BQ33947137-B52FE643-E4FB-48E4-A8A8-CF7EEB82B64FQ34458350-3C9916E0-0CE5-4C74-93FF-FC0EAA1D2E80Q34981243-5AD0E9A3-BCF8-4E74-AFAC-908326852950Q35233946-8F8921FC-13C4-4E8E-BD1F-3F4C364DC086Q35788511-D3DDCF4F-ECEF-40E2-9BAB-23C1371FF39CQ35998417-2BDB5A50-54A7-4F34-945F-B291F8EB1A76Q36119466-C03598F5-F39E-476A-A073-0AC1DEBC0339Q36267674-62730454-B3AD-4721-9B8E-9B9C72E431A4Q36370253-334C11E5-2E99-405E-899C-C7B0BFAD21D6Q36669743-82587247-2C08-45C7-B772-CE57ADE94D05Q36803801-A86C6272-6C49-48ED-B82D-EC9ABE54B421Q36906342-582A3311-67B0-4BD2-A75A-FADBAB0DB50CQ37122676-5569D95B-9E62-44F9-B6B4-BE0AB7F1132EQ37362448-D289EA4C-1E5A-4740-BBE6-ECAEF6D927C8Q38649701-3FD59E1C-7626-4033-AB6A-5EEF6A3EFC6DQ39970004-2B2C4AEC-6EDA-42AB-9BC3-8BD0EB6713D8Q40049823-F13488E6-3FB6-4C86-BDD3-119F0AF9B769Q40126436-4C3B7614-A1F3-4CCF-AF2A-794DFCC84EC0Q41697463-CE9198E8-8FB9-4A70-B8EC-F129A6BC4DAEQ42622742-5D4F1714-78EC-407D-8958-A11831359340Q42663450-BC8DF27B-0FEB-418A-842B-8B3DEA46721AQ42671832-F731F585-1027-453B-9E8D-73D07628F014Q45085512-7D90CFF2-0958-437F-BAFD-223446AD3F5DQ46000139-0A3BEC24-D00A-42EA-8BDA-A15DC2933B0FQ52304099-20232333-08D5-4C9F-B816-C9FEFDC4F461Q57773626-31C92CF9-9DE6-482D-B109-983B31B205BF
P2860
High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
High-prevalence and high-estim ...... rge scale prevention programs.
@ast
High-prevalence and high-estim ...... rge scale prevention programs.
@en
High-prevalence and high-estim ...... rge scale prevention programs.
@nl
type
label
High-prevalence and high-estim ...... rge scale prevention programs.
@ast
High-prevalence and high-estim ...... rge scale prevention programs.
@en
High-prevalence and high-estim ...... rge scale prevention programs.
@nl
prefLabel
High-prevalence and high-estim ...... rge scale prevention programs.
@ast
High-prevalence and high-estim ...... rge scale prevention programs.
@en
High-prevalence and high-estim ...... rge scale prevention programs.
@nl
P2093
P2860
P356
P1476
High-prevalence and high-estim ...... rge scale prevention programs.
@en
P2093
Don Des Jarlais
Jack Dehovitz
Katri Abel
Kristi Rüütel
Kristiina Rajaleid
Lucy Platt
P2860
P304
P356
10.1093/PUBMED/FDN014
P577
2008-02-28T00:00:00Z